(Press-News.org) CALGARY – A three-month-old Winnipeg girl has become the first patient in Canada to receive an experimental and potentially life-saving form of therapy to improve the function of her liver.
Physicians at Alberta Children's Hospital, led by medical geneticist Dr. Aneal Khan, successfully completed a series of liver cell transplants earlier this month on patient Nazdana Ali.
Nazdana was born last August with a Urea Cycle Disorder (UCD), a genetic disease that causes ammonia to build up in the body that, if untreated, would lead to brain damage and death. Ammonia is naturally produced as the body uses protein but, for those with UCDs, the process of converting ammonia to urea (a harmless substance which gives urine its yellow colour) does not work properly.
The condition is incurable and very rare: Alberta Children's Hospital treats about two children with a UCD per year. In Canada, about 50 babies are born annually with the condition.
Each time ammonia builds up, there is a risk of neurological damage but transplanted liver cells are expected to help Nazdana's liver to keep the ammonia down to safe levels.
"We have been monitoring Nazdana closely and are happy to report that she has tolerated the liver cell transplant well, she is stable and can return home to Winnipeg," says Dr. Khan, who is also an assistant professor of medical genetics and pediatrics at the University of Calgary, and a member of the U of C-AHS Alberta Children's Hospital Research Institute for Child and Maternal Health. "This could represent a big leap forward in managing these cases. It's a promising new bridge therapy that could improve the odds of Nazdana surviving until she is able to undergo a liver transplant."
The long-term stabilization of ammonia levels resulting from liver cell infusion buys children time until a matching liver can be found and transplanted.
To date the procedure has been performed in Germany, including an operation on a Canadian baby, and in a handful of centres in the U.S.
Without conventional treatment, most newborns with a UCD die within the first two weeks of life. Special medications and a protein-restricted diet improve survival rates but the brain remains exposed to high ammonia levels and even children who survive have a high risk of brain damage. The only long-term treatment is a liver transplant but a transplant in a small child has less chance of success and there is limited availability of organs.
Nazdana's procedures took place over six days earlier this month at Alberta Children's Hospital, with each infusion taking about an hour. It is part of a research trial sponsored by the biotechnology firm Cytonet LLC, which covered all costs for the procedures, hospitalizations, blood tests and related expenses. Through a complex process, Cytonet transforms liver cells from donor organs that would otherwise go to waste, into cells that can be transplanted.
Nazdana currently weighs about 4.5 kilograms and ideally will have to reach a weight of at least seven kilograms before the chances of a successful organ transplant improve. In the meantime, the small amount of transplanted liver cells allow her to get the nutrition, including protein, she needs to grow while helping to keep her ammonia under control.
Nazdana's father, Jouhar Ali, is grateful for the care his daughter has received.
"The health care people – the nurses and the doctors – they have all been outstanding. I have no words to explain it," says Ali. "I really appreciate and am very thankful for what they have done."
The current study allows for three patients to be enrolled. Dr. Khan expects the next candidate for liver cell transfusion will be a baby from southern Alberta who is currently hospitalized for management of high ammonia levels.
"It's largely because of the organizational support we have through Alberta Health Services and the University of Calgary that we were able to be the first in Canada to perform this therapy,"
Dr. Khan says. "In particular, it took the coordination and support of a great many people at Alberta Children's Hospital to make this happen."
Alberta Health Services is the provincial health authority responsible for planning and delivering health supports and services for more than 3.8 million adults and children living in Alberta. Its mission is to provide a patient-focused, quality health system that is accessible and sustainable for all Albertans.
###
Still photos and video of one of Nazdana's liver cell infusion procedures are available at
ftp://208.118.126.84 NOTE: videos are too large to stream; they must be downloaded for playback.
User name: media
Password: share
Folder: ACH-CELL-THERAPY
For media inquiries, contact:
Greg Harris
AHS Communications
403-943-2911
403-619-3108 (cell)
About The Alberta Children's Hospital Research Institute for Child and Maternal Health (ACHRI)
ACHRI is a multi-disciplinary Partnership Institute of the University of Calgary, Alberta Health Services and the Alberta Children's Hospital Foundation – the membership of which encompasses the Faculties of Arts, Engineering, Medicine, Veterinary Medicine, Nursing, Kinesiology, Science and Social Work. http://research4kids.ucalgary.ca/
About the University of Calgary's Faculty of Medicine
UCalgary's Faculty of Medicine is a national leader in health research with an international reputation for excellence and innovation in health care research, education and delivery. The Faculty of Medicine trains the next generation of health practitioners and moves new treatments and diagnostic techniques from the laboratory bench to the hospital bedside, improving patient care. For more information, visit medicine.ucalgary.ca or follow them on twitter.com.
About Cytonet
Cytonet is an internationally active biotechnology company which is located in Weinheim and Heidelberg in Germany and in Durham, NC in the U.S. The company develops and produces cell therapeutic products. Cytonet's goal is to provide alternatives to existing therapies for many diseases with a particular emphasis on liver diseases. Cytonet is a pioneer and leader in the field of regenerative medicine. For the past several years, Cytonet has worked with internationally-leading metabolism and neonatal centers to study its liver cell therapy, which uses healthy and metabolically functional human liver cells collected from donated livers not suitable for transplant for infusion to treat urea cycle disorders in children. For more information, please visit Cytonet's website at http://www.cytonetllc.com/
Canada's first liver cell transplant takes place in Calgary
2012-11-29
ELSE PRESS RELEASES FROM THIS DATE:
Sources of E. coli are not always what they seem
2012-11-29
This press release is available in Spanish.
U.S. Department of Agriculture (USDA) scientists have identified sources of Escherichia coli bacteria that could help restore the reputation of local livestock. Studies by Agricultural Research Service (ARS) scientist Mark Ibekwe suggest that in some parts of California, pathogens in local waterways are more often carried there via runoff from urban areas, not from animal production facilities.
ARS is USDA's chief intramural scientific research agency, and this work supports the USDA priority of ensuring food safety.
Even ...
The beginning of everything: A new paradigm shift for the infant universe
2012-11-29
A new paradigm for understanding the earliest eras in the history of the universe has been developed by scientists at Penn State University. Using techniques from an area of modern physics called loop quantum cosmology, developed at Penn State, the scientists now have extended analyses that include quantum physics farther back in time than ever before -- all the way to the beginning. The new paradigm of loop quantum origins shows, for the first time, that the large-scale structures we now see in the universe evolved from fundamental fluctuations in the essential quantum ...
Precisely engineering 3-D brain tissues
2012-11-29
CAMBRIDGE, MA -- Borrowing from microfabrication techniques used in the semiconductor industry, MIT and Harvard Medical School (HMS) engineers have developed a simple and inexpensive way to create three-dimensional brain tissues in a lab dish.
The new technique yields tissue constructs that closely mimic the cellular composition of those in the living brain, allowing scientists to study how neurons form connections and to predict how cells from individual patients might respond to different drugs. The work also paves the way for developing bioengineered implants to replace ...
Running too far, too fast, and too long speeds progress 'to finish line of life'
2012-11-29
Vigorous exercise is good for health, but only if it's limited to a maximum daily dose of between 30 and 50 minutes, say researchers in an editorial published online in Heart.
The idea that more and more high intensity exercise, such as marathons, can only do you good, is a myth say the US cardiologists, and the evidence shows that it's likely to more harm than good to your heart.
"If you really want to do a marathon or full distance triathlon, etc, it may be best to do just one or a few and then proceed to safer and healthier exercise patterns," they warn.
"A routine ...
Can a genetic variation in the vitamin D receptor protect against osteoporosis?
2012-11-29
New Rochelle, NY, November 29, 2012—Osteoporosis, or reduced bone mineral density that can increase the risk of fractures, may affect as many as 30% of women and 12% of men worldwide. One risk factor for osteoporosis is vitamin D deficiency. A modified form of the vitamin D receptor present in some individuals may lower their risk for developing osteoporosis, according to an article in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Genetic Testing and Molecular Biomarkers website.
To ...
Post-divorce journaling may hinder healing for some
2012-11-29
Following a divorce or separation, many people are encouraged by loved ones or health-care professionals to keep journals about their feelings. But for some, writing in-depth about those feelings immediately after a split may do more harm than good, according to new research.
In a study of 90 recently divorced or separated individuals, psychological scientist David Sbarra of the University of Arizona and colleagues found that writing about one's feelings can actually leave some people feeling more emotionally distraught months down the line, particularly those individuals ...
Drug may offer new approach to treating insomnia
2012-11-29
MINNEAPOLIS – A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The drug, suvorexant, blocks the chemical messengers in the brain called orexins, which regulate wakefulness. Other drugs for insomnia affect different brain receptors.
Taking the drug suvorexant increased the amount of time people spent asleep during the night, according to the study. The study involved 254 people ages 18 to 64 who were in good physical and ...
Tiny algae shed light on photosynthesis as a dynamic property
2012-11-29
One of the first chemical reactions children learn is the recipe for photosynthesis, combining carbon dioxide, water and solar energy to produce organic compounds. Many of the world's most important photosynthetic eukaryotes such as plants did not develop the ability to combine these ingredients themselves. Rather, they got their light-harnessing organelles -- chloroplasts -- indirectly by stealing them from other organisms. In some instances, this has resulted in algae with multiple, distinct genomes, the evolutionary equivalent of a "turducken*."
Chloroplasts originally ...
Morality-based judgments are quicker, more extreme than practical evaluations
2012-11-29
Judgments made after a moral evaluation are quicker and more extreme than the same judgment based on practical considerations, but morality-based evaluations can be more easily shifted and made with other considerations in mind, according to research published November 28 in the open access journal PLOS ONE by Jay Van Bavel and colleagues from New York University.
Previous research has suggested that moral reasoning usually occurs after a person makes a decision, as a post hoc justification of their choice, rather than the basis for the decision itself. This new study ...
More omnivore dilemmas: Seasonal diet changes can cause reproductive stress in primates
2012-11-29
When seasonal changes affect food availability, omnivores like blue monkeys adapt by changing their diets, but such nutritional changes may impact female reproduction, according to research published November 28 in the open access journal PLOS ONE by Steffen Foerster from Barnard College, and colleagues from Columbia University and the Smithsonian Institution.
The authors found that levels of fecal glucocorticoids (fGC), a stress marker, increased when female monkeys shifted their diet towards lower quality fallback foods, whereas the levels decreased when the monkeys ...